Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05264389

Post-market Clinical Follow-up (PMCF) Study of the Poly-Tape Devices for Medial Patellofemoral Ligament (MPFL) Reconstruction

Status
Recruiting
Phase
Study type
Observational
Enrollment
59 (estimated)
Sponsor
Xiros Ltd · Industry
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

This is a Post Market Clinical Follow Up Study in Orthopaedics. It will verify the long-term safety and performance of the device in the intended patient population, when indicated for the reconstruction of a ligament in the kneecap - the Medial Patellofemoral Ligament (MPFL). The Medical Devices in this study, 10mm Poly-Tape and 5mm Infinity-Lock Tape, are Class III CE-Marked devices manufactured by Xiros Ltd. Both devices fall under the Poly-Tape family. Poly-Tapes are single-use devices, they are indicated for patients requiring soft tissue approximation and reconstruction of ligaments and tendons. The device can be fixed to the bone using several different methods, including screws. This study is a prospective, multicentre, consecutively recruited non-randomised study. The total length of the study is expected to be 7 years. This includes a recruitment period of approximately 24 months and a 5-year follow-up. A total of 55 subjects will be enrolled into the study with follow up at 6 months, 1 year, 2 years and 5 years in clinic and by questionnaires. All subjects treated with either the 10mm Poly-Tape or 5mm Infinity-Lock Tape for MPFL reconstruction, will be consecutively recruited into the study.

Conditions

Interventions

TypeNameDescription
DEVICEPoly-Tape DevicesPoly-Tape Devices, 10mm Poly-Tape or 5mm Infinity-Lock Tape, for Medial Patellofemoral Ligament (MPFL) Reconstruction

Timeline

Start date
2022-09-05
Primary completion
2026-09-01
Completion
2031-09-01
First posted
2022-03-03
Last updated
2026-01-27

Locations

5 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05264389. Inclusion in this directory is not an endorsement.